Results Recap: Post-Market Results From Avinger's Pantheris Peripheral OCT System; Nemaura Announces sugarBEAT CGM Results
Executive Summary
This week's edition of Medtech Insight's Results Recap, the weekly roundup of major device trial-results from Meddevicetracker.com, includes preliminary analysis of results from Avinger's SCAN clinical study, a 12-patient, 240-image post-market study of Avinger's Pantheris optical coherence tomography in the peripheral arteries and results of an 18-patient early-feasibility study showing Nativis' Voyager device is safe for treatment of recurrent glioblastoma.
You may also be interested in...
Nemaura’s SugarBEAT Non-Invasive CGM Earns CE Mark
SugarBEAT is a non-invasive, needle-free, disposable adhesive skin-patch connected to a rechargeable transmitter. The company says it is the world’s first non-invasive continuous glucose monitor.
News We’re Watching: FDA Approves Medtronic's Affera, Roche's CGM Moves Closer To Approval, And More
Medtech Insight's News We're Watching covers medtech industry and research news you may have missed. This week, the Advanced Technologies and Treatments for Diabetes (ATTD) conference in Florence, Italy, included new results from studies of Roche's continuous glucose monitor and Medtronic's 780G insulin pump, Medtronic moved closer to earning FDA approval for its Affera ablation mapping and ablation system, and Linus Health expanded its technology for finding signs of cognitive problems in speech data.
New’s We’re Watching: J&J's Varipulse PFA Earns CE Mark; Labs Create Intravascular Robots; And More
Medtech Insight's News We're Watching highlights some recent business and R&D developments you may have missed. This week, Biosense Webster’s Varipulse PFA platform earned a CE mark; Biosense Webster also announced the start the pivotal IDE study of its Laminar left atrial appendage elimination system; the FDA approved Boston Scientific's Agent paclitaxel-coated balloon and cleared Medtronic's OsteoCool 2.0 bone ablation system; three papers in Science Robotics describe magnetically controlled vascular robots that could go places wires and catheters cannot.